In 57 patients with multiple myeloma, our results showed that the proportion of CD3+CD4+ cells and CD4+/CD8+ significantly decreased in peripheral blood compared with healthy controls (Table 5). This evidence concerns the gene CD8A and plasma cell myeloma.